Percutaneous In Situ Coronary Venous Arterialization
- 29 May 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (21) , 2539-2543
- https://doi.org/10.1161/01.cir.103.21.2539
Abstract
Abstract —Diffuse coronary artery disease is frequently untreatable by coronary artery bypass or angioplasty. Many such “no-option” patients have been subjects for trials of angiogenesis using growth factor manipulation or laser injury. We think these novel revascularization strategies are limited by insufficient inflow to putative areas of new microvasculature and thus seek a more mechanical solution. We report the use of a catheter-based system for arterializing the adjacent anterior cardiac vein in a patient with chronic total occlusion of the left anterior descending coronary artery. A composite catheter system (phased-array ultrasound imaging system mounted on a catheter with extendable nitinol needle) was used to deliver an exchange-length intracoronary guidewire from the proximal left anterior descending coronary artery into the parallel anterior interventricular vein. Using standard angioplasty techniques, a fistula was then constructed from the proximal artery to the coronary vein using a self-expanding connector. The proximal vein was blocked with a novel self-expanding “blocker,” thus precluding “steal” through the coronary sinus and forcing retroperfusion of the anterior wall. The procedure was completed without complication, and a follow-up angiogram at 3 months confirmed continued patency of the arteriovenous connection. This patient, who had severe angina before the procedure, has been asymptomatic for 12 months. Percutaneous in situ venous arterialization may be an effective therapy for diffuse, “untreatable” coronary disease by supplying a robust inflow of arterialized blood via retroperfusion to severely ischemic myocardium.Keywords
This publication has 17 references indexed in Scilit:
- Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trialThe Lancet, 2000
- Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial PerfusionCirculation, 2000
- Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory AnginaNew England Journal of Medicine, 1999
- Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trialThe Lancet, 1999
- Angiogenesis Is Enhanced in Ischemic Canine Myocardium by Transmyocardial Laser RevascularizationJournal of the American College of Cardiology, 1998
- Transmyocardial laser revascularization: Results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery diseaseThe Journal of Thoracic and Cardiovascular Surgery, 1997
- Evaluation of Regional Myocardial Nutrient Perfusion Following Selective Retrograde Arterialization of the Coronary VeinThe Annals of Thoracic Surgery, 1978
- Coronary Venous Retroperfusion for Myocardial RevascularizationThe Annals of Thoracic Surgery, 1975
- REVASCULARIZATION OF HEART BY GRAFT OF SYSTEMIC ARTERY INTO CORONARY SINUSJAMA, 1948